null
US
Sign In
Sign Up for Free
Sign Up
We have detected that Javascript is not enabled in your browser. The dynamic nature of our site means that Javascript must be enabled to function properly. Please read our
terms and conditions
for more information.
Next up
Copy and Edit
You need to log in to complete this action!
Register for Free
11607779
Respiratory Drugs
Description
Pharmacology 214.202 Massey university NZ
Mind Map by
Samara Watts
, updated more than 1 year ago
More
Less
Created by
Samara Watts
almost 7 years ago
28
0
0
Resource summary
Respiratory Drugs
Bronchodilators
B2 adrenergic agonists
Short acting
Salbutamol, terbutaline
used for actue asthma
Long acting
eformoterol, salmeterol
used as a symptom controller
MOA: Stimulate B2 adrenergic receptors on the bronchial smooth muscles and stimulates sympathetic nervous system response - causing bronchodilation.
Adverse effects: tremors, tachycardia, headache, increased blood glucose levels,
Antimuscarinics
Short acting
Ipratropium
Long acting
tiotropium, glycopyrronium
Theraputic action: bronchodilation, decreased mucous secretion action
MOA: block muscarinic receptors and inhibit the parasympathetic nervous system
Adverse reactions: dry mouth/throat irritation, blurred vision.
Methylxanthines
Theophylline, aminophylline
Theraputic action: increased cellular activity and bronchodilation
MOA: inhibits the enzyme that degrades cAMP
Adverse reactions: insomnia, anxiety, tremors, tachycardia, nausea
Preventer drug
Leukotriene receptor antagonists
Montelukast
Theraputic Action: mediate inflammatory reactions
MOA: blocks action of inflammation mediators
Adverse effects: headache, GI upset, thirst
Mast cell stabilisers
Sodium cromoglycale
Theraputic action: preventer group
MOA: prevents release of inflammatory mediators from mast cells
Adverse effects: Throat irritation, nausea
Steriods
Steroidal Anti-iinflammatory
Systemic corticosteriods
Prednisone, Methylprednisolone
Inhaled corticosteriods
Beclometasone, Fluticasone
Theraputic Action: bronchoconstriction and inflammation decreation
MOA: inhibits rupture of mast cells, decreases inflammatory mediators, suppresses antibody production and immune cells.
Adverse reactions: Fluid and electrolyte imbalance, immunosuppressence
Combined formulations
Seretide & Symbicort
Show full summary
Hide full summary
Want to create your own
Mind Maps
for
free
with GoConqr?
Learn more
.
Similar
THEMES IN KING LEAR
Sarah-Elizabeth
situation ethics
96arthur.g
English Grammatical Terminology
Fionnghuala Malone
CUMULATIVE FREQUENCY DIAGRAMS
Elliot O'Leary
Revision Time Table
jessica3008
Spanish Subjunctive
MrAbels
Animal Farm
010534
All AS Maths Equations/Calculations and Questions
natashaaaa
AQA Biology B2 Unit 2.1 - Cells Tissues and Organs
BeccaElaine
AQA GCSE Physics Unit 2 Mindmap
Gabi Germain
Types of Learning Environment
Brandon Tuyuc
Browse Library